MediShield Life Scheme (Amendment No. 2) Regulations 2022

No. S 769

MediShield Life Scheme Act 2015

MediShield Life Scheme
(Amendment No. 2)
Regulations 2022

In exercise of the powers conferred by section 34 of the MediShield Life Scheme Act 2015, the Minister for Health makes the following Regulations:

Citation and commencement

1. These Regulations are the MediShield Life Scheme (Amendment No. 2) Regulations 2022 and come into operation on 1 October 2022.

Amendment of regulation 2

2. In regulation 2 of the MediShield Life Scheme Regulations 2015 (G.N. No. S 622/2015) (called in these Regulations the principal Regulations) —

(a)

in paragraph (1), after the definition of “approved in‑patient palliative care institution”, insert —

“ “Approved Indications for PBT” means Approved Indications for Use of Proton Beam Therapy in Treatment published on the website of the Ministry of Health at https://www.moh.gov.sg;”;

(b)

in paragraph (1), after the definition of “approved private hospital”, insert —

“ “approved proton beam therapy” means any radiotherapy treatment or radiosurgery treatment using proton beam therapy for a clinical indication listed in the Approved Indications for PBT;”;

(c)

in paragraph (1), replace the definition of “radiosurgery treatment” with —

“ “radiosurgery treatment” means the treatment of neurosurgical or neurological disorders using any of the following:

(a)

gamma knife technology;

(b)

linear accelerator technology;

(c)

proton beam therapy for a Category 4 clinical indication listed in the Approved Indications for PBT;

(d)

externally generated ionising radiation delivered using —

(i)	a rigidly attached stereotactic guiding device or other immobilisation technology; or
(ii)	a stereotactic image‑guidance system,

but excludes stereotactic radiotherapy;”; and

(d)

after paragraph (3), insert —

“(4) In these Regulations, in relation to admissions before 1 October 2022, “radiosurgery treatment” means the gamma knife treatment or the Novalis shaped beam treatment of neurosurgical or neurological disorders.”.

Amendment of Third Schedule

3. In the Third Schedule to the principal Regulations, after paragraph 21, insert —

“22. Any proton beam therapy, except approved proton beam therapy.”.

Amendment of Sixth Schedule

4. In the Sixth Schedule to the principal Regulations, in item 8, after paragraph (e), insert —

“(f)	Approved proton beam therapy for a Category 1 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 October 2022

$300 per treatment

(g)	Approved proton beam therapy for a Category 2 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 October 2022

$500 per treatment

(h)	Approved proton beam therapy for a Category 3 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 October 2022

$1,800 per treatment”.

[G.N. Nos. S 300/2018; S 465/2018; S 731/2018; S 190/2019; S 286/2019; S 866/2019; S 192/2020; S 224/2020; S 898/2020; S 933/2020; S 135/2021; S 711/2022]

Made on 29 September 2022.

CHAN YENG KIT

Permanent Secretary,
Ministry of Health,
Singapore.

[MH 96:27/12; AG/LEGIS/SL/176A/2020/1 Vol. 2]

(To be presented to Parliament under section 34(4) of the MediShield Life Scheme Act 2015).

Search within Legislation